Factor VIII assay variability in postinfusion samples containing full length and B-domain deleted FVIII.
about
The History of Clotting Factor Concentrates PharmacokineticsThe use of pharmacokinetics in dose individualization of factor VIII in the treatment of hemophilia A.Measurement of B-domain-deleted ReFacto AF activity with a product-specific standard is affected by choice of reagent and patient-specific factors.
P2860
Factor VIII assay variability in postinfusion samples containing full length and B-domain deleted FVIII.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Factor VIII assay variability ...... th and B-domain deleted FVIII.
@en
Factor VIII assay variability ...... th and B-domain deleted FVIII.
@nl
type
label
Factor VIII assay variability ...... th and B-domain deleted FVIII.
@en
Factor VIII assay variability ...... th and B-domain deleted FVIII.
@nl
prefLabel
Factor VIII assay variability ...... th and B-domain deleted FVIII.
@en
Factor VIII assay variability ...... th and B-domain deleted FVIII.
@nl
P2093
P2860
P356
P1433
P1476
Factor VIII assay variability ...... th and B-domain deleted FVIII.
@en
P2093
D P Kitchen
I D Walker
I Jennings
T A L Woods
P2860
P304
P356
10.1111/HAE.12962
P577
2016-05-24T00:00:00Z